Anxiety and Related Sleep Disorders - G20

  • G20
  • Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$6.68bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.53%, resulting in a market volume of US$6.86bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,213.00m in 2024).
  • In relation to total population figures, per person revenues of US$37.37 are generated in 2024.

Key regions: China, United States, Germany, India, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Anxiety and Related Sleep Disorders market in G20 is experiencing significant growth due to increasing customer preferences for natural and holistic remedies, as well as the rising prevalence of anxiety and sleep disorders globally.

Customer preferences:
Customers in the Anxiety and Related Sleep Disorders market are increasingly seeking natural and holistic remedies for their conditions. This shift in preference can be attributed to a growing awareness of the potential side effects and dependency issues associated with traditional pharmaceutical treatments. As a result, there has been a surge in demand for alternative therapies such as herbal supplements, aromatherapy, and mindfulness practices. Additionally, customers are also looking for personalized solutions that cater to their specific needs and lifestyles.

Trends in the market:
One of the key trends in the Anxiety and Related Sleep Disorders market is the growing adoption of digital health solutions. With the increasing use of smartphones and other mobile devices, customers are now able to access a wide range of digital tools and platforms that provide support and guidance for managing anxiety and sleep disorders. These solutions include mobile apps for meditation and relaxation, virtual therapy sessions, and wearable devices that track sleep patterns and provide personalized recommendations. The convenience and accessibility of these digital solutions have made them popular among customers, especially the younger demographic.

Local special circumstances:
In each country within the G20, there are unique circumstances that contribute to the development of the Anxiety and Related Sleep Disorders market. For example, in countries with high levels of stress and work-related pressure, such as Japan and South Korea, there is a greater demand for products and services that help individuals manage anxiety and improve sleep quality. On the other hand, in countries with a higher prevalence of mental health disorders, such as the United States and Canada, there is a greater focus on developing comprehensive treatment plans that address both anxiety and sleep disorders.

Underlying macroeconomic factors:
The growth of the Anxiety and Related Sleep Disorders market in the G20 is also influenced by underlying macroeconomic factors. For instance, the increasing disposable income and healthcare expenditure in emerging economies such as China and India have led to a rise in demand for anxiety and sleep disorder treatments. Additionally, the aging population in many G20 countries, including Japan and Germany, has contributed to the growth of the market, as older individuals are more susceptible to these conditions. Furthermore, the COVID-19 pandemic has also had a significant impact on the market, with the increased stress and uncertainty leading to a higher prevalence of anxiety and sleep disorders globally.In conclusion, the Anxiety and Related Sleep Disorders market in the G20 is experiencing growth due to customer preferences for natural and holistic remedies, the increasing adoption of digital health solutions, unique local circumstances, and underlying macroeconomic factors. As the market continues to evolve, it is expected that there will be further advancements in treatment options and an increased focus on personalized and integrated approaches to managing anxiety and sleep disorders.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)